Johns Hopkins HIV Guide
Tenofovir AF
INDICATIONS
FDA
FDA
Treatment of HIV-1 infection as part of a single-tablet regimen (STR), Genvoya or Odefsey, or NRTI combination tablet Descovy, for adults and pediatric patients 12 years of age and older who are treatment naive or to replace the current antiretroviral regimen in those who are virologically suppressed
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 8, 2016
Citation
Smith, Janessa M. "Tenofovir AF." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545252/all/Tenofovir_AF.
Smith JM. Tenofovir AF. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545252/all/Tenofovir_AF. Accessed September 27, 2023.
Smith, J. M. (2016). Tenofovir AF. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545252/all/Tenofovir_AF
Smith JM. Tenofovir AF [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 September 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545252/all/Tenofovir_AF.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tenofovir AF
ID - 545252
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2016/11/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545252/all/Tenofovir_AF
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
